Loading stock data...

Everest Organics Limited

BSE: EVERESTO

BSE
500.35 -4.15 (-0.82%)

Prev Close

504.5

Open Price

504.5

Volume

1,630

Today Low / High

500 / 513.95

52 WK Low / High

210.95 / 536.4

Range

475 - 525

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 500.35, reflecting a change of -4.15 (-0.8226%). The expected target range on the BSE is 475 - 525. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

29 Dec 463.00 2.81%
26 Dec 475.00 -3.53%
24 Dec 453.00 5.08%
23 Dec 475.45 -4.92%
22 Dec 455.00 1.71%
19 Dec 476.00 -5.16%
18 Dec 470.00 -1.71%
17 Dec 480.00 -0.96%
16 Dec 473.80 1.86%
15 Dec 494.95 -4.75%
12 Dec 489.95 -2.95%
11 Dec 477.70 0.44%
10 Dec 485.00 -2.68%

Everest Organics Limited Graph

Everest Organics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Everest Organics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 500.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 500.35 505.35 454.82 - 555.89
510.36 408.29 - 612.43
515.36 360.75 - 669.97
Bearish Scenario 500.35 495.35 445.81 - 544.88
490.34 392.27 - 588.41
485.34 339.74 - 630.94

Overview of Everest Organics Limited

ISIN

INE334C01029

Industry

Medical - Distribution

Vol.Avg

4,985

Market Cap

4,622,210,376

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

576.81

DCF

-119

Financial Ratios Every Investor Needs

Stock Dividend of EVERESTO

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2022-09-15 September 15, 22 0.5 0.5 2022-09-16 2022-10-24
2021-09-08 September 08, 21 1 1 2021-09-10 2021-10-18
2021-02-17 February 17, 21 0.5 0.5 2021-02-18 2021-03-10
2020-09-01 September 01, 20 1 1 2020-09-02 2020-10-08
2019-09-03 September 03, 19 1 1 2019-09-04 2019-10-10

Stock Rating Details for EVERESTO

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 4 Buy
ROA Score 4 Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 159.48 Cr 98.54 Cr 60.94 Cr 0.3821 1.85 Cr 17.41 Cr 1.26 Cr -1.29 Cr -1.61 7.91 Cr -0.0081
2024-03-31 197.24 Cr 154.62 Cr 42.62 Cr 0.2161 2.22 Cr 3.93 Cr 5.94 Cr 0.14 Cr 0.17 11.25 Cr 0.0007
2023-03-31 183.05 Cr 174.29 Cr 8.75 Cr 0.0478 0.52 Cr 10.56 Cr -3.50 Cr -0.18 Cr -0.23 7.87 Cr -0.0010
2022-03-31 200.05 Cr 184.87 Cr 15.17 Cr 0.0758 2.28 Cr 16.33 Cr 2.74 Cr 1.14 Cr 1.43 8.64 Cr 0.0057
2021-03-31 181.57 Cr 151.18 Cr 30.39 Cr 0.1674 2.22 Cr 15.26 Cr 19.52 Cr 13.72 Cr 17.14 23.90 Cr 0.0755

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 6.09 Cr 224.48 Cr 154.54 Cr 69.9469 Cr 47.87 Cr 41.78 Cr 45.25 Cr 69.71 Cr 0.00 Cr 0.00 Cr 0.08 Cr 139.9244 Cr
2024-03-31 0.83 Cr 226.72 Cr 180.88 Cr 45.8399 Cr 57.79 Cr 56.96 Cr 43.76 Cr 71.67 Cr 0.00 Cr 0.00 Cr 0.08 Cr 160.1012 Cr
2023-03-31 0.83 Cr 201.85 Cr 155.63 Cr 46.2149 Cr 51.05 Cr 50.22 Cr 47.28 Cr 63.96 Cr 0.02 Cr 0.00 Cr 0.32 Cr 137.5823 Cr
2022-03-31 0.65 Cr 178.00 Cr 131.20 Cr 46.7970 Cr 41.13 Cr 38.13 Cr 42.55 Cr 57.00 Cr 0.29 Cr 0.00 Cr 0.34 Cr 112.5623 Cr
2021-03-31 1.66 Cr 135.38 Cr 88.80 Cr 46.5756 Cr 22.90 Cr 21.24 Cr 34.24 Cr 43.64 Cr 3.02 Cr 0.00 Cr 0.29 Cr 77.3608 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -5.3769 Cr -5.1693 Cr 16.3648 Cr -10.8034 Cr 5.8186 Cr 6.0920 Cr -3.5771 Cr -3.2426 Cr -5.4453 Cr 0.0000 Cr -1.4834 Cr
2024-03-31 16.0932 Cr -12.9964 Cr -3.0986 Cr 3.3268 Cr -0.0014 Cr 0.2734 Cr -13.0933 Cr 0.1392 Cr 2.3679 Cr 0.0000 Cr 2.9716 Cr
2023-03-31 18.4155 Cr -15.2304 Cr -3.0450 Cr 1.4206 Cr 0.1773 Cr 0.8288 Cr -13.7203 Cr -0.1822 Cr 0.6645 Cr -0.4000 Cr -5.2454 Cr
2022-03-31 10.6886 Cr -16.8700 Cr 5.1712 Cr -6.4661 Cr -1.0102 Cr 0.6515 Cr -17.1547 Cr 1.1437 Cr 5.1712 Cr -0.8000 Cr -8.5666 Cr
2021-03-31 10.3861 Cr -11.9275 Cr 1.2019 Cr 3.5366 Cr -0.3395 Cr 1.6617 Cr -6.8495 Cr 13.7150 Cr 1.2019 Cr -1.2000 Cr -5.5246 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 51.00 Cr 32.77 Cr 18.23 Cr 0.3575 3.62 Cr 1.16 Cr 1.19 5.42 Cr 0.0227
2025-06-30 53.81 Cr 37.05 Cr 16.76 Cr 0.3115 2.92 Cr 1.41 Cr 1.45 4.99 Cr 0.0261
2025-03-31 40.93 Cr 24.89 Cr 16.04 Cr 0.3919 1.88 Cr 2.91 Cr 3.00 3.65 Cr 0.0712
2024-12-31 42.05 Cr 25.34 Cr 16.71 Cr 0.3973 2.55 Cr 1.14 Cr 1.42 4.02 Cr 0.0271
2024-09-30 44.05 Cr 26.07 Cr 17.98 Cr 0.4082 1.96 Cr 0.74 Cr 0.93 3.57 Cr 0.0168

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.49 Cr 1.21 Cr 1.70 Cr 115.44 Cr 37.80 Cr 161.16 Cr 67.46 Cr 236.98 Cr 164.47 Cr
2025-06-30 0.00 Cr 0.00 Cr 6.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -69.95 Cr
2025-03-31 6.09 Cr 0.55 Cr 7.25 Cr 88.43 Cr 45.25 Cr 147.90 Cr 69.71 Cr 224.48 Cr 154.54 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -40.49 Cr
2024-09-30 0.24 Cr 0.76 Cr 1.00 Cr 91.22 Cr 45.88 Cr 143.92 Cr 70.59 Cr 219.86 Cr 179.37 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 2.91 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -6.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Distribution

No stocks found in this industry.

Key Executives

MD, CEO & Executive Director
Sirisha Sri Kakarlapudi

Gender: Not Specified

Year Born: 1977

Purchase Head & Materials Manager
Dora

Gender: male

Year Born: 1969

Chief Financial Officer
Peruri Ramakrishna

Gender: male

Year Born: 1966

Whole Time Director
Srikakarlapudi Harikrishna

Gender: male

Year Born: 1979

Company Secretary & Compliance Officer
Shweta Singh

Gender: female

Year Born:

Assistant General Manager of Marketing
Thumma Sumana

Gender: Not Specified

Year Born: 1979

Manager
Atluri Siva Kumar

Gender: Not Specified

Year Born: 1983

FAQs about Everest Organics Limited

Who is the CEO of the company?

The CEO is Sirisha Sri Kakarlapudi.

What is the current market price of the stock?

The current price is ₹476.00.

What is the 52-week price range?

The range is ₹210.95-499.

What is the market capitalization of the company?

The market capitalization is ₹462.22 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 69.91.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Everest Organics Limited (ISIN: INE334C01029) is a leading Medical - Distribution in India. With a market capitalization of ₹462.22 crores and an average daily volume of 4,985 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.